Part of the DODS Group DODS Group Logo
Register for our newsletter
Menu
The Parliament Magazine

Subscribe to The Parliament Magazine

Subscribe now
Subscribe now
  • News
  • Opinion
  • MEP Awards
  • Interviews
  • PM+
  • Policy
    • Agriculture & Food
    • Tech & Research
    • Industry & Finance
    • Energy & Climate
    • International & Trade
    • Health
    • EU Institutions
    • Justice
    • Jobs & Social Rights
    • Security & Defence
    • Mobility
    • Regions & Cities
  • Dods Political Intelligence
  • Magazine
  • Events
  • More
    • About The Parliament Magazine
    • Newsletters & Registration
    • Contact Us
    • Vacancies
Search

Follow us:

  • News
  • Opinion
  • MEP Awards
  • Interviews
  • PM+
  • Policy
    • Agriculture & Food
    • Tech & Research
    • Industry & Finance
    • Energy & Climate
    • International & Trade
    • Health
    • EU Institutions
    • Justice
    • Jobs & Social Rights
    • Security & Defence
    • Mobility
    • Regions & Cities
  • Dods Political Intelligence
  • Magazine
  • Events
  • More
    • About The Parliament Magazine
    • Newsletters & Registration
    • Contact Us
    • Vacancies

Author Profile

Full list of news written by this author
Pfizer

Pfizer

@pfizer

Time for a New Model to Tackle Cancer Care Disparities Partner Content
29 Jun Tech & Research
Time for a New Model to Tackle Cancer Care Disparities
Berfu Yaziyurt of Pfizer and MEP Bartosz Arłukowicz call on the EU to tackle disparities in cancer care at a European level, using a multidisciplinary model.
Rare Diseases: Time for Innovation Partner Content
27 Jun Tech & Research
Rare Diseases: Time for Innovation
Pfizer's Reda Guiha and MEP Maria da Graça Carvalho want to see the EU do more to deliver on its promise for people living with a rare disease, by supporting research in new medical innovations.
How do we solve the rare disease crisis? Partner Content
27 May Tech & Research
How do we solve the rare disease crisis?
Pfizer often made the headlines over the past year after mobilising their scientific expertise and manufacturing capabilities to respond to the COVID-19 pandemic. Reda Guiha, Regional President for Rare Disease at Pfizer, argues that the same sense of urgency and public-private sector collaboration that brought vaccines to patients within a year should be applied to other areas of critical unmet medical need, such as rare disease.
A monthly magazine delivered to you and packed with the latest opinion and analysis
Subscribe

Subscribe to The Parliament Magazine

Subscribe now

Follow us

Registered office: 11th Floor, The Shard, 32 London Bridge Street, London SE1 9SG

Company number: 04267888

© Merit Group plc

Quick Links
  • Home
  • News
  • Opinion
  • Interviews
  • PM+
  • Policy
  • EU Political Intelligence
  • Magazine
  • Events
Services
  • Dods People
  • Dods Political Intelligence
  • Dods Research
  • Dods Events
  • Dods Training
Media & Publishing
  • PoliticsHome
  • Holyrood
  • Civil Service World
  • The House Magazine
  • PublicTechnology
  • Training Journal
  • Subscribe to Dods media titles
About Dods
  • Dods Group
  • Part of Merit Group
  • Privacy Policy
  • Terms & Conditions
  • Advertising
  • Sponsorship
  • Subscriptions